• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Privia Health Group Inc. (Amendment)

    5/12/23 4:05:11 PM ET
    $PRVA
    Medical/Nursing Services
    Health Care
    Get the next $PRVA alert in real time by email
    SC 13G/A 1 formsc13ga.htm

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

    (Amendment No. 3)*

     

    Privia Health Group, Inc.

     
    (Name of Issuer)

     

    Common Stock, $0.01 par value per share

     
    (Title of Class of Securities)

     

    74276R102

     
    (CUSIP Number)

     

    May 8, 2023
    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ☐ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☒ Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    CUSIP No. 74276R102 SCHEDULE 13G  

     

    1

    NAME OF REPORTING PERSONS

     

    Pamplona Capital Partners III, L.P.

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ☐

    (b) ☐

    3

    SEC USE ONLY

     

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Cayman Islands

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    0

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    0

    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0%

    12

    TYPE OF REPORTING PERSON

     

    PN

     

     

     

     


    CUSIP No. 74276R102 SCHEDULE 13G  

             
    1

    NAME OF REPORTING PERSONS

     

    Pamplona Equity Advisors III Ltd.

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ☐

    (b) ☐

     
    3

    SEC USE ONLY

     

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Cayman Islands

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    0

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    0

    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.0%

    12

    TYPE OF REPORTING PERSON

     

    CO

     

     

     

     


    CUSIP No. 74276R102  SCHEDULE 13G  

             
    1

    NAME OF REPORTING PERSONS

     

    Pamplona Private Equity Carryco III, L.P.

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ☐

    (b) ☐

     
    3

    SEC USE ONLY

     

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Cayman Islands

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    0

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    0

    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.0%

    12

    TYPE OF REPORTING PERSON

     

    PN

     

     

     

     


    CUSIP No. 74276R102 SCHEDULE 13G  

             
    1

    NAME OF REPORTING PERSONS

     

    Pamplona Equity Carryco Advisors III, Ltd.

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ☐

    (b) ☐

     
    3

    SEC USE ONLY

     

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Cayman Islands

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    0

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    0

    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.0%

    12

    TYPE OF REPORTING PERSON

     

    CO

     

     

     

     


    CUSIP No. 74276R102 SCHEDULE 13G  

             
    1

    NAME OF REPORTING PERSONS

     

    Pamplona PE Investments II, Ltd.

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ☐

    (b) ☐

     
    3

    SEC USE ONLY

     

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Cayman Islands

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    0

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    0

    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.0%

    12

    TYPE OF REPORTING PERSON

     

    CO

     

     

     

     


    CUSIP No. 74276R102 SCHEDULE 13G  

             
    1

    NAME OF REPORTING PERSONS

     

    Pamplona PE Investments Malta Limited

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ☐

    (b) ☐

     
    3

    SEC USE ONLY

     

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Malta

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    0

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    0

    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.0%

    12

    TYPE OF REPORTING PERSON

     

    CO

     

     

     

     


    CUSIP No. 74276R102 SCHEDULE 13G  

             
    1

    NAME OF REPORTING PERSONS

     

    Pamplona Capital Management LLP

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ☐

    (b) ☐

     
    3

    SEC USE ONLY

     

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United Kingdom

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    0

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    0

    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.0%

    12

    TYPE OF REPORTING PERSON

     

    PN

     

     

     

     


    CUSIP No. 74276R102 SCHEDULE 13G  

             
    1

    NAME OF REPORTING PERSONS

     

    Pamplona Capital Management LLC

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ☐

    (b) ☐

     
    3

    SEC USE ONLY

     

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    0

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    0

    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.0%

    12

    TYPE OF REPORTING PERSON

     

    OO

     

     

     

     



    CUSIP No. 74276R102 SCHEDULE 13G  

             
    1

    NAME OF REPORTING PERSONS

     

    John C. Halsted

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ☐

    (b) ☐

     
    3

    SEC USE ONLY

     

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    0

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    0

    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.0%

    12

    TYPE OF REPORTING PERSON

     

    IN

     

     

     

     

    CUSIP No. 74276R102 SCHEDULE 13G  

             
    1

    NAME OF REPORTING PERSONS

     

    Alexander M. Knaster

    2

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ☐

    (b) ☐

     
    3

    SEC USE ONLY

     

     

    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United Kingdom

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

    5

    SOLE VOTING POWER

     

    0

    6

    SHARED VOTING POWER

     

    0

    7

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    0

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    0

    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     

    ☐
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    0.0%

    12

    TYPE OF REPORTING PERSON

     

    IN

     

     

     

     

    CUSIP No. 74276R102 SCHEDULE 13G  

     

    Item 1. (a) Name of Issuer

     

    Privia Health Group, Inc. (the “Issuer”)

     

    Item 1. (b) Address of Issuer’s Principal Executive Offices

     

    950 N. Glebe Rd., Suite 700, Arlington, Virginia 22203

     

    Item 2. (a, b, c) Names of Person Filing, Address of Principal Business Office, Citizenship:

     

    This report on Schedule 13G is being filed by (i) Pamplona Capital Partners III, L.P., a Cayman Islands exempted limited partnership (“PCP III”), (ii) Pamplona Equity Advisors III Ltd., a Cayman Islands exempted company (“PEA III”), (iii) Pamplona Private Equity Carryco III, L.P., a Cayman Islands exempted limited partnership (“PPEC III”), (iv) Pamplona Equity Carryco Advisors III, Ltd, a Cayman Islands exempted company (“PECA III”), (v) Pamplona PE Investments II, Ltd., a Cayman Islands exempted company (“PPEI”), (vi) Pamplona PE Investments Malta Limited, a Malta limited company (“PE Malta”), (vii) Pamplona Capital Management LLP, a United Kingdom limited liability partnership (“PCM LLP”), (viii) Pamplona Capital Management LLC, a Delaware limited liability company (“PCM LLC, and together with PCM LLP, the “Pamplona Manager Entities”), (ix) John C. Halsted, a citizen of the United States, and (x) Alexander M. Knaster, a citizen of the United Kingdom (collectively, the “Reporting Persons”).

     

    The address for the Reporting Persons is: c/o Pamplona Capital Management LLC, 667 Madison Avenue, 22nd Floor, New York, NY 10065.

     

    Item 2. (d) Title of Class of Securities

     

    Common Stock, $0.01 par value per share (the “Common Stock”)

     

    Item 2. (e) CUSIP No.:

     

    74276R102

     

    Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person filing is a:

     

    N/A

     

     

     

     

    CUSIP No. 74276R102 SCHEDULE 13G  

     

    Item 4. Ownership

     

    As reported in the cover pages to this report, the ownership information with respect to the Reporting Persons is as follows:

     

    (a) Amount Beneficially Owned: 0

     

    (b) Percent of Class: 0.0%

     

    (c) Number of Shares as to which such person has:

     

    (i) Sole power to vote or to direct the vote: 0

     

    (ii) Shared power to vote or to direct the vote: 0

     

    (iii) Sole power to dispose or to direct the disposition of: 0

     

    (iv) Shared power to dispose or to direct the disposition of: 0

     

    Pursuant to an underwriting agreement, dated May 4, 2023 (the “Underwriting Agreement”), and in connection with a registered secondary offering and sale of Common Stock by the selling stockholders listed on Schedule I to the Underwriting Agreement, PCP III sold 13,483,709 shares of Common Stock and PPEC III sold 4,258,014 shares of Common Stock at a purchase price of $21.615 per share.

     

    As of May 8, 2023, PCP III and PPEC III held 0 shares of Common Stock. PCP III is controlled by PEA III, its general partner. PPEI owns 100% of the shares of PEA III. Mr. Alexander Knaster owns 100% of the shares of PPEI. PE Malta serves as an investment manager to PCP III. The Pamplona Manager Entities serve as investment advisors to PE Malta. Mr. Halsted and Mr. Knaster are the principals of the Pamplona Manager Entities. PPEC III is controlled by PECA III, its general partner. PPEI owns 100% of the shares of PECA III. As a result of the foregoing, for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended, each of PEA III, PPEC III, PECA III, PPEI, PE Malta, the Pamplona Manager Entities, Mr. Halsted and Mr. Knaster may be deemed to beneficially own shares of Common Stock held by PCP III and PPEC III.

     

    Item 5. Ownership of Five Percent or Less of a Class

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X].

     

    Item 6. Ownership of More Than Five Percent on Behalf of Another Person

     

    Not Applicable.

     

    Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

     

    Not Applicable.

     

    Item 8. Identification and Classification of Members of the Group

     

    Not Applicable.

     

    Item 9. Notice of Dissolution of Group

     

    Not Applicable.

     

    Item 10. Certification

     

    Not applicable.

     

     

     

    Exhibit Index

     

    1. Joint Filing Agreement dated as of February 14, 2023, by and between Pamplona Capital Partners III, L.P., Pamplona Equity Advisors III Ltd., Pamplona Private Equity Carryco III, L.P., Pamplona Equity Carryco Advisors III, Ltd., Pamplona PE Investments II, Ltd., Pamplona PE Investments Malta Limited, Pamplona Capital Management LLP and Pamplona Capital Management LLC (incorporated by reference to Exhibit 1 to the Schedule 13G/A filed with the Securities and Exchange Commission on February 14, 2023).

     

     

     

     

    CUSIP No. 74276R102 SCHEDULE 13G  

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: May 12, 2023

     

    Pamplona Capital Partners III, L.P.  
       
    By: Pamplona Equity Advisors III Ltd., its general partner  
         
    By: /s/ Ronan Guilfoyle  
      Ronan Guilfoyle, Director  
         
    Pamplona Equity Advisors III Ltd.  
         
    By: /s/ Ronan Guilfoyle  
      Ronan Guilfoyle, Director  
         
    Pamplona Private Equity Carryco III, L.P.  
       

    By:

    Pamplona Equity Carryco Advisors III, Ltd., its general partner

     
         
    By: /s/ Ronan Guilfoyle  
      Ronan Guilfoyle, Director  
         
    Pamplona Equity Carryco Advisors III, Ltd.  
         
    By: /s/ Ronan Guilfoyle  
      Ronan Guilfoyle, Director  
         
    Pamplona PE Investments II, Ltd.  
         
    By: /s/ Ronan Guilfoyle  
      Ronan Guilfoyle, Director  
         
    Pamplona PE Investments Malta Limited  
         
    By: /s/ Stephen Gauci  
      Stephen Gauci, Director  
         
    Pamplona Capital Management LLP  
         
    By: /s/ Kevin O’Flaherty  
      Kevin O’Flaherty, Designated Member  
         
    Pamplona Capital Management LLC  
         
    By: /s/ Stephen Gauci  
      Stephen Gauci, Managing Member  
         
      /s/ John C. Halsted  
      John C. Halsted  
         
      /s/ Alexander M. Knaster  
      Alexander M. Knaster  

     

     

     

    Get the next $PRVA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PRVA

    DatePrice TargetRatingAnalyst
    1/9/2026$31.00Outperform
    RBC Capital Mkts
    11/13/2025$30.00Outperform
    BMO Capital Markets
    1/10/2025$25.00Buy
    Needham
    12/16/2024Outperform
    Macquarie
    10/11/2024$23.00Overweight
    KeyBanc Capital Markets
    5/30/2024$23.00Outperform
    Robert W. Baird
    4/22/2024$25.00Buy
    Citigroup
    3/6/2024$22.00Equal Weight
    Barclays
    More analyst ratings

    $PRVA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital Mkts initiated coverage on Privia Health with a new price target

    RBC Capital Mkts initiated coverage of Privia Health with a rating of Outperform and set a new price target of $31.00

    1/9/26 8:12:05 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    BMO Capital Markets initiated coverage on Privia Health with a new price target

    BMO Capital Markets initiated coverage of Privia Health with a rating of Outperform and set a new price target of $30.00

    11/13/25 9:16:05 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Needham initiated coverage on Privia Health with a new price target

    Needham initiated coverage of Privia Health with a rating of Buy and set a new price target of $25.00

    1/10/25 7:58:16 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    $PRVA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Boehler Adam bought $6,006 worth of shares (364 units at $16.50) (SEC Form 4)

    4 - Privia Health Group, Inc. (0001759655) (Issuer)

    6/13/24 4:05:22 PM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Boehler Adam bought $87,549 worth of shares (5,306 units at $16.50) (SEC Form 4)

    4 - Privia Health Group, Inc. (0001759655) (Issuer)

    5/31/24 4:13:08 PM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Boehler Adam bought $70,577 worth of shares (4,280 units at $16.49) (SEC Form 4)

    4 - Privia Health Group, Inc. (0001759655) (Issuer)

    5/29/24 4:08:14 PM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    $PRVA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Privia Health to Report Fourth Quarter 2025 Results on Thursday, February 26

    ARLINGTON, Va., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it expects to release financial results for its fourth-quarter and twelve-month periods ended December 31, 2025 before market open on Thursday, February 26, 2026. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, February 26, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-a

    1/22/26 9:00:00 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Privia Health Reports Third Quarter 2025 Financial Results

    Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1% compared to 3Q'24FY'25 Guidance Raised Above High End for All Key Operating and Financial Metrics ARLINGTON, Va., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the third quarter ended September 30, 2025. Third Quarter Performance   For the Three Months Ended September 30,  ($ in millions, except per share amounts)  2025  2024 Change (%) fTotal revenue $580.4 $437.9 32.5%Gross profit $122.6 $99.9 22.7%Operating income $14.4 $5.8 1

    11/6/25 6:00:00 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Privia Health to Report Third Quarter 2025 Results on Thursday, November 6

    ARLINGTON, Va., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it expects to release financial results for its third-quarter and nine-month periods ended September 30, 2025 before market open on Thursday, November 6, 2025. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, November 6, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-e

    10/7/25 9:00:00 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    $PRVA
    SEC Filings

    View All

    SEC Form 144 filed by Privia Health Group Inc.

    144 - Privia Health Group, Inc. (0001759655) (Subject)

    12/12/25 6:31:33 PM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Privia Health Group Inc. filed SEC Form 8-K: Other Events

    8-K - Privia Health Group, Inc. (0001759655) (Filer)

    12/8/25 8:01:00 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    SEC Form S-3ASR filed by Privia Health Group Inc.

    S-3ASR - Privia Health Group, Inc. (0001759655) (Filer)

    11/6/25 4:14:27 PM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    $PRVA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Morris Matthew Shawn exercised 13,647 shares at a strike of $2.00 and sold $341,311 worth of shares (13,647 units at $25.01) (SEC Form 4)

    4 - Privia Health Group, Inc. (0001759655) (Issuer)

    12/16/25 4:38:11 PM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    EVP & Chief Financial Officer Mountcastle David exercised 23,887 shares at a strike of $2.00 and sold $597,892 worth of shares (23,887 units at $25.03) (SEC Form 4)

    4 - Privia Health Group, Inc. (0001759655) (Issuer)

    12/16/25 4:37:23 PM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Director Berberian Lance was granted 7,668 shares (SEC Form 4)

    4 - Privia Health Group, Inc. (0001759655) (Issuer)

    7/17/25 4:04:31 PM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    $PRVA
    Leadership Updates

    Live Leadership Updates

    View All

    Privia Health Expands Value-Based Care Footprint with Acquisition of Accountable Care Organization Business from Evolent Health

    ARLINGTON, Va., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) announced that it signed a definitive agreement to acquire an Accountable Care Organization (ACO) business from Evolent Health, Inc. (NYSE:EVH). The ACO business cares for over 120,000 attributed lives through the Medicare Shared Savings Program (MSSP), as well as various commercial and Medicare Advantage programs. With this transaction, Privia Health will now serve approximately 1.5 million attributed lives in value-based care (VBC) arrangements across commercial, Medicare, Medicare Advantage and Medicaid. Privia Health will pay $100 million in cash at closing and up to an additional $13 million su

    9/23/25 4:10:00 PM ET
    $EVH
    $PRVA
    Other Consumer Services
    Consumer Discretionary
    Medical/Nursing Services
    Health Care

    Privia Health Announces Appointment of Lance V. Berberian to its Board of Directors

    ARLINGTON, Va., July 08, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) announced the appointment of Lance V. Berberian to its Board of Directors, effective July 15, 2025. He has also been named a member of the Audit Committee of the Board. Following the appointment of Mr. Berberian, the Board will comprise 10 directors. "We are excited to welcome Lance to our Board of Directors," said David King, Chairman of the Board, Privia Health Group, Inc. "Lance brings extensive technology strategy and digital transformation experience to the Board, including IT governance, infrastructure management and cybersecurity. We believe his expertise will be invaluable to Privia Health as

    7/8/25 9:00:00 AM ET
    $LH
    $PRVA
    Medical Specialities
    Health Care
    Medical/Nursing Services

    Privia Health Appoints Edward C. Fargis as General Counsel

    ARLINGTON, Va., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) announced that Edward C. Fargis has been named Executive Vice President, General Counsel and Corporate Secretary, effective today. Mr. Fargis will serve as the Company's chief legal officer, working with Privia executive leadership to support the Company's long-term direction and growth. "Ed is a proven leader who brings an invaluable healthcare industry perspective as well as extensive experience managing corporate governance, compliance and strategic transactions," said Parth Mehrotra, CEO, Privia Health. "As Privia continues to grow and our industry evolves, we are fortunate to have Ed joining us

    1/29/24 8:30:00 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    $PRVA
    Financials

    Live finance-specific insights

    View All

    Privia Health to Report Fourth Quarter 2025 Results on Thursday, February 26

    ARLINGTON, Va., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it expects to release financial results for its fourth-quarter and twelve-month periods ended December 31, 2025 before market open on Thursday, February 26, 2026. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, February 26, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-a

    1/22/26 9:00:00 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Privia Health Reports Third Quarter 2025 Financial Results

    Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1% compared to 3Q'24FY'25 Guidance Raised Above High End for All Key Operating and Financial Metrics ARLINGTON, Va., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the third quarter ended September 30, 2025. Third Quarter Performance   For the Three Months Ended September 30,  ($ in millions, except per share amounts)  2025  2024 Change (%) fTotal revenue $580.4 $437.9 32.5%Gross profit $122.6 $99.9 22.7%Operating income $14.4 $5.8 1

    11/6/25 6:00:00 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Privia Health to Report Third Quarter 2025 Results on Thursday, November 6

    ARLINGTON, Va., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it expects to release financial results for its third-quarter and nine-month periods ended September 30, 2025 before market open on Thursday, November 6, 2025. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, November 6, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-e

    10/7/25 9:00:00 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    $PRVA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Privia Health Group Inc.

    SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)

    11/14/24 5:20:21 PM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Privia Health Group Inc.

    SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)

    11/12/24 10:34:17 AM ET
    $PRVA
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Privia Health Group Inc.

    SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)

    7/10/24 1:14:41 PM ET
    $PRVA
    Medical/Nursing Services
    Health Care